Sumitomo Mitsui Trust Group’s 10x Genomics TXG Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$204M	Sell	2,258,734 -1,935,893	-46%	-$113M	0.12%	161
2026 Q2	$161M	Sell	4,194,627 -915,587	-18%	-$24M	0.09%	208
2026 Q1	$108M	Sell	5,110,214 -381,975	-7%	-$7.64M	0.07%	258
2025 Q4	$89.6M	Buy	5,492,189 +110,970	+2%	+$1.68M	0.05%	316
2025 Q3	$62.9M	Sell	5,381,219 -636,744	-11%	-$8.3M	0.04%	402
2025 Q2	$69.7M	Buy	6,017,963 +654,597	+12%	+$5.97M	0.04%	370
2025 Q1	$46.8M	Sell	5,363,366 -350,118	-6%	-$4.41M	0.03%	458
2024 Q4	$82M	Sell	5,713,484 -659,728	-10%	-$10.4M	0.06%	327
2024 Q3	$144M	Buy	6,373,212 +230,145	+4%	+$4.76M	0.1%	198
2024 Q2	$119M	Buy	6,143,067 +2,521,289	+70%	+$66M	0.09%	218
2024 Q1	$136M	Buy	3,621,778 +1,338,248	+59%	+$58.8M	0.09%	224
2023 Q4	$128M	Buy	2,283,530 +565,059	+33%	+$24.6M	0.09%	222
2023 Q3	$70.9M	Sell	1,718,471 -47,163	-3%	-$2.45M	0.06%	357
2023 Q2	$98.6M	Sell	1,765,634 -255,435	-13%	-$13.8M	0.08%	280
2023 Q1	$113M	Sell	2,021,069 -156,919	-7%	-$7.33M	0.08%	258
2022 Q4	$79.4M	Sell	2,177,988 -29,270	-1%	-$957K	0.06%	358
2022 Q3	$62.9M	Buy	2,207,258 +793,419	+56%	+$30.2M	0.05%	413
2022 Q2	$64M	Sell	1,413,839 -204,514	-13%	-$10.6M	0.05%	418
2022 Q1	$123M	Buy	1,618,353 +184,168	+13%	+$16.1M	0.08%	275
2021 Q4	$214M	Sell	1,434,185 -90,020	-6%	-$13.8M	0.13%	175
2021 Q3	$222M	Sell	1,524,205 -215,169	-12%	-$36.9M	0.14%	160
2021 Q2	$341M	Buy	1,739,374 +518,185	+42%	+$93.8M	0.2%	114
2021 Q1	$221M	Buy	1,221,189 +904,239	+285%	+$156M	0.14%	173
2020 Q4	$44.9M	Buy	316,950 +214,682	+210%	+$31.2M	0.03%	569
2020 Q3	$12.8M	Sell	102,268 -105,915	-51%	-$11.1M	0.01%	739
2020 Q2	$18.6M	Buy	+208,183	New	+$16.2M	0.01%	688

Other funds holding TXG

Counterpoint Mutual Funds San Diego, California $1.16B AUM 33.78% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Convergence Investment Partners Palm Beach Gardens, Florida $1.35B AUM 71.9% 1-Year Est. Return

Cookson Peirce & Co Pittsburgh, Pennsylvania $2.77B AUM 64.09% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $6.11B AUM 3.71% 1-Year Est. Return

Financial Consulate Hunt Valley, Maryland $899M AUM 14.82% 1-Year Est. Return

MIC

Maxi Investments CY Limassol, Cyprus $545M AUM 21.2% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Empirical Wealth Management Seattle, Washington $7.38B AUM 22.9% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Sumitomo Mitsui Trust Group's TXG Position: Q3 2026 in Review

Sumitomo Mitsui Trust Group reduced its 10x Genomics (TXG) stake by 46% in Q3 2026, selling an estimated $113M and leaving 2,258,734 shares worth $204M. The position accounts for 0.12% of the portfolio, ranked #161.

Sumitomo Mitsui Trust Group first reported a position in TXG in Q2 2020 and has held it in 26 quarters since. The position peaked at $341M in Q2 2021. 126 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

Sumitomo Mitsui Trust Group held 2,258,734 shares of 10x Genomics worth $204M as of Q3 2026.
Sumitomo Mitsui Trust Group sold 1,935,893 10x Genomics shares in Q3 2026, an estimated $113M.
10x Genomics made up 0.12% of Sumitomo Mitsui Trust Group's portfolio in Q3 2026, its #161 holding.
Sumitomo Mitsui Trust Group first reported a position in 10x Genomics in Q2 2020 and has held it in 26 quarters since.
Sumitomo Mitsui Trust Group's 10x Genomics position peaked at $341M in Q2 2021.
126 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q3 2026, filed 29 Oct 2026.